Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1038/s41467-020-18463-z

http://scihub22266oqcxt.onion/10.1038/s41467-020-18463-z
suck pdf from google scholar
32943628!7499305!32943628
unlimited free pdf from europmc32943628    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid32943628      Nat+Commun 2020 ; 11 (1): 4682
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis #MMPMID32943628
  • Shannon A; Selisko B; Le NT; Huchting J; Touret F; Piorkowski G; Fattorini V; Ferron F; Decroly E; Meier C; Coutard B; Peersen O; Canard B
  • Nat Commun 2020[Sep]; 11 (1): 4682 PMID32943628show ga
  • The ongoing Corona Virus Disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has emphasized the urgent need for antiviral therapeutics. The viral RNA-dependent-RNA-polymerase (RdRp) is a promising target with polymerase inhibitors successfully used for the treatment of several viral diseases. We demonstrate here that Favipiravir predominantly exerts an antiviral effect through lethal mutagenesis. The SARS-CoV RdRp complex is at least 10-fold more active than any other viral RdRp known. It possesses both unusually high nucleotide incorporation rates and high-error rates allowing facile insertion of Favipiravir into viral RNA, provoking C-to-U and G-to-A transitions in the already low cytosine content SARS-CoV-2 genome. The coronavirus RdRp complex represents an Achilles heel for SARS-CoV, supporting nucleoside analogues as promising candidates for the treatment of COVID-19.
  • |Amides/pharmacokinetics/*pharmacology[MESH]
  • |Animals[MESH]
  • |Antiviral Agents/pharmacokinetics/*pharmacology[MESH]
  • |Betacoronavirus/*drug effects/*genetics[MESH]
  • |COVID-19[MESH]
  • |COVID-19 Drug Treatment[MESH]
  • |Chlorocebus aethiops[MESH]
  • |Coronavirus Infections/*drug therapy/virology[MESH]
  • |Coronavirus RNA-Dependent RNA Polymerase[MESH]
  • |Models, Molecular[MESH]
  • |Mutagenesis/drug effects[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*drug therapy/virology[MESH]
  • |Pyrazines/pharmacokinetics/*pharmacology[MESH]
  • |RNA, Viral/genetics/metabolism[MESH]
  • |RNA-Dependent RNA Polymerase/chemistry/metabolism[MESH]
  • |SARS-CoV-2[MESH]
  • |Sequence Analysis[MESH]
  • |Vero Cells[MESH]
  • |Viral Nonstructural Proteins/chemistry/metabolism[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box